Taro Expands Branded Over-the-Counter Portfolio in U.S. with the Launch of FeverAll ® Liquid Oral Acetaminophen for Children Ages 2-11

New oral liquid format expands the FeverAll® family of products, giving parents more options from the doctor-recommended suppository brand. HAWTHORNE, N.Y., March 6, 2024 /PRNewswire-PRWeb/ -- Taro Pharmaceuticals U.S.A., Inc., a subsidiary of Taro Pharmaceutical Industries Ltd. (NYSE:...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: PDT Source Type: news